BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to Balance Sheet
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Net Current Assets History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-58 Cr | ₹-36 Cr | ₹-30 Cr | ₹-7.69 Cr | ₹10 Cr |
What is the latest Net Current Assets ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹-58 Cr |
Mar2022 | ₹-36 Cr |
Mar2021 | ₹-30 Cr |
Mar2020 | ₹-7.69 Cr |
Mar2019 | ₹10 Cr |
How is Net Current Assets of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹-58 Cr | Negative | |
Mar2022 | ₹-36 Cr | Negative | |
Mar2021 | ₹-30 Cr | Negative | |
Mar2020 | ₹-7.69 Cr | Negative | |
Mar2019 | ₹10 Cr | - |
Compare Net Current Assets of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹131.2 Cr | -5.6% | 2.8% | 26.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -5.6% |
2.8% |
26.5% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses